Boots, a major UK pharmacy chain, will become the first in the country to privately prescribe cannabis to patients with specific conditions such as insomnia, chronic pain, and generalized anxiety. Patients must first attempt traditional treatments and undergo screening for conditions like psychosis before being eligible for the prescription. The cannabis will be provided through Boots' online doctor service, Sureleaf, requiring a video consultation. The move follows Boots' acquisition by a Canadian firm, which has experience with medical cannabis legalization. The initiative emphasizes clinical oversight and individualized assessments to ensure safe and effective treatment.
Bias read (Center): The article presents factual information about Boots' new service without overtly favoring either side, using neutral language and citing official statements from Boots representatives.




